News and Announcements
SEER 10 cent capital raising is closing
- Published September 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
We are delighted to announce that Seer Asset Management has enjoyed overwhelming interest from investors keen to learn more about the six mega trends we’ve identified as critically shaping the future world economy and our focus on sustainable, responsible and impact investing (SRI) in the global industries of science, technology and innovation (STI).
At the time of writing, Seer has raised close to $1 million in shareholder equity, securing cornerstone investors and is now seeking to encourage investors to consider the Offer.
The Information Memorandum offering $0.10 per Converting Preference Share will be closed on the 1st October 2018.
As a Wholesale and or Sophisticated Investor this will equate to:
- An un-franked dividend payment (November 2018 and May 2019),
- Converting Preference Shares,
- Free Options and
- Upon conversion of the Converting Preference Shares you will receive Fully Paid Ordinary Shares.
We invite you to consider this investment opportunity before it closes.
An online Application form is found at seeram.com.au
About Seer Asset Management:
Seer Asset Management will be a diversified funds management group specialising in alternative assets and sustainable investment strategies. We see out investment approach as an opportunity for investors to participate in a multi-thematic strategy, that through positive impact investing will aim to offer risk-adjusted returns to investors focusing on growth opportunities.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
